BioSpace News Archive

FDA

UTILITY Receives Investigational New Drug Approval from US FDA

UTILITY therapeutics Ltd today announces that the US Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) applications for mecillinam (injectable) and pivmecillinam (oral prodrug).

September 19, 2018
·
3 min read
I-Mab Wins Frost & Sullivan “2018 Best R&D Innovator Award (Biopharma Category)”

I-Mab Biopharma announced today that it has been recognized by Forest & Sullivan, the global leading growth consulting company as well as the biggest growth consulting company in China, with the “2018 Best R&D Innovator (Biopharma Category)” award.

September 19, 2018
·
5 min read
Business

Abzena Announces a Research and Licence Agreement with Tmunity Therapeutics, a T Cell Engineering Company

Abzena, plc has signed an antibody humanisation agreement with Tmunity Therapeutics

September 19, 2018
·
4 min read
FDA

OBI Pharma Granted FDA Orphan Drug Designation for OBI-3424 for the Treatment of Acute Lymphoblastic Leukemia (ALL)

Second Orphan Drug Designation for OBI-3424, a novel first-in-class targeted therapy for solid and liquid tumors that express aldo-keto reductase 1c3 (AKR1C3) enzyme

September 19, 2018
·
4 min read
Biotech Bay

The Moore Foundation Doubles Down on Support for Quantum Materials

Boosts basic scientific research with $95 million for the next six years

September 19, 2018
·
5 min read
Biotech Beach

DermTech Announces Enrollment Completion of Clinical Study to Assess DNA Damage and Reversal

DermTech, Inc. announced today it has completed enrollment in a clinical study to assess DNA damage induced by an excimer laser and evaluate the potential of topical agents T4 endonuclease and photolyase to reduce DNA damage induced as measured through gene expression analysis.

September 19, 2018
·
1 min read
Pharm Country

Where Would Your Physician Go For Care?

Medscape 2018 Physicians’ Choice Survey Ranks Top Hospitals for Serious Conditions, Including Cancer

September 19, 2018
·
9 min read
Job Trends

University of Phoenix Survey Finds US Adults Say There Are Too Many Unknowns About Old Age to Make it Worth Living to 100

People are not willing to make positive lifestyle changes now, such as quitting smoking, to live well in later years

September 19, 2018
·
5 min read
Business

Zymeworks Names Anthony Polverino, Ph.D., Executive Vice President of Early Development and Chief Scientific Officer

Zymeworks Inc. today announced it has named Anthony (Tony) Polverino, Ph.D., Executive Vice President of Early Development and Chief Scientific Officer.

September 19, 2018
·
5 min read
Business

Zynx Health Introduces ZynxPeds Order Sets and Care Plans Developed in Partnership with Akron Children’s Hospital

ZynxPeds equips community hospitals with pediatric-specific content to enhance the delivery of care

September 19, 2018
·
4 min read